Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 16.70
0.00 (0.00%)
At close: Mar 13, 2026
Bio-View Market Cap
Bio-View has a market cap or net worth of 22.38 million as of March 13, 2026. Its market cap has decreased by -39.24% in one year.
Market Cap
22.38M
Enterprise Value
16.40M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.70
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 22.38M, a decrease of -62.57%. That is a compound annual growth rate of -4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 22.38M | - |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 104.64B |
| Danel (Adir Yeoshua) | 2.61B |
| BrainsWay | 1.66B |
| Kamada | 1.58B |
| BioLight Life Sciences | 29.72M |
| Identi Healthcare | 28.05M |
| Evogene | 23.03M |
| XTL Biopharmaceuticals | 19.87M |